Suivre
Marcus P. Watkins
Marcus P. Watkins
Adresse e-mail validée de wustl.edu
Titre
Citée par
Citée par
Année
Nutrient regulates Tor1 nuclear localization and association with rDNA promoter
H Li, CK Tsang, M Watkins, PG Bertram, XFS Zheng
Nature 442 (7106), 1058-1061, 2006
2792006
Low peak bone mass and attenuated anabolic response to parathyroid hormone in mice with an osteoblast-specific deletion of connexin43
DJ Chung, CHM Castro, M Watkins, JP Stains, MY Chung, VL Szejnfeld, ...
Journal of cell science 119 (20), 4187-4198, 2006
1892006
The conditional connexin43G138R mouse mutant represents a new model of hereditary oculodentodigital dysplasia in humans
R Dobrowolski, P Sasse, JW Schrickel, M Watkins, JS Kim, M Rackauskas, ...
Human molecular genetics 17 (4), 539-554, 2008
1802008
Osteoblast connexin43 modulates skeletal architecture by regulating both arms of bone remodeling
M Watkins, SK Grimston, JY Norris, B Guillotin, A Shaw, E Beniash, ...
Molecular biology of the cell 22 (8), 1240-1251, 2011
1702011
Bone turnover in bone biopsies of patients with low-energy cortical fractures receiving bisphosphonates: a case series
R Armamento-Villareal, N Napoli, K Diemer, M Watkins, R Civitelli, ...
Calcified tissue international 85, 37-44, 2009
1482009
N-cadherin and cadherin 11 modulate postnatal bone growth and osteoblast differentiation by distinct mechanisms
A Di Benedetto, M Watkins, S Grimston, V Salazar, C Donsante, ...
Journal of cell science 123 (15), 2640-2648, 2010
1382010
Connexin43 deficiency reduces the sensitivity of cortical bone to the effects of muscle paralysis
SK Grimston, DB Goldberg, M Watkins, MD Brodt, MJ Silva, R Civitelli
Journal of Bone and Mineral Research 26 (9), 2151-2160, 2011
892011
Enhanced periosteal and endocortical responses to axial tibial compression loading in conditional connexin43 deficient mice
SK Grimston, MP Watkins, MD Brodt, MJ Silva, R Civitelli
Public Library of Science 7 (9), e44222, 2012
782012
Molecular mechanisms of osteoblast/osteocyte regulation by connexin43
JP Stains, MP Watkins, SK Grimston, C Hebert, R Civitelli
Calcified tissue international 94, 55-67, 2014
752014
p62 is required for stem cell/progenitor retention through inhibition of IKK/NF-κB/Ccl4 signaling at the bone marrow macrophage-osteoblast niche
KH Chang, A Sengupta, RC Nayak, A Duran, SJ Lee, RG Pratt, ...
Cell reports 9 (6), 2084-2097, 2014
692014
Single-route CNS prophylaxis for aggressive non-Hodgkin lymphomas: real-world outcomes from 21 US academic institutions
VM Orellana-Noia, DR Reed, AA McCook, JM Sen, CM Barlow, ...
Blood, The Journal of the American Society of Hematology 139 (3), 413-423, 2022
622022
Bisphosphonates improve trabecular bone mass and normalize cortical thickness in ovariectomized, osteoblast connexin43 deficient mice
MP Watkins, JY Norris, SK Grimston, X Zhang, RJ Phipps, FH Ebetino, ...
Bone 51 (4), 787-794, 2012
492012
Accentuated ovariectomy‐induced bone loss and altered osteogenesis in heterozygous N‐cadherin null mice
CF Lai, SL Cheng, G Mbalaviele, C Donsante, M Watkins, GL Radice, ...
Journal of Bone and Mineral Research 21 (12), 1897-1906, 2006
412006
Postnatal ablation of osteoblast Smad4 enhances proliferative responses to canonical Wnt signaling through interactions with β-catenin
VS Salazar, N Zarkadis, L Huang, M Watkins, J Kading, S Bonar, J Norris, ...
Journal of cell science 126 (24), 5598-5609, 2013
402013
CD19-targeted immunotherapies for treatment of patients with non-Hodgkin B-cell lymphomas
MP Watkins, NL Bartlett
Expert Opinion on Investigational Drugs 27 (7), 601-611, 2018
322018
Microfibril-associated glycoprotein-1, an extracellular matrix regulator of bone remodeling
CS Craft, W Zou, M Watkins, S Grimston, MD Brodt, TJ Broekelmann, ...
Journal of biological chemistry 285 (31), 23858-23867, 2010
312010
Connexin43 modulates post-natal cortical bone modeling and mechano-responsiveness
SK Grimston, MP Watkins, JP Stains, R Civitelli
BoneKEy reports 2, 2013
252013
N‐cadherin Regulation of Bone Growth and Homeostasis Is Osteolineage Stage–Specific
F Fontana, CL Hickman‐Brecks, VS Salazar, L Revollo, G Abou‐Ezzi, ...
Journal of Bone and Mineral Research 32 (6), 1332-1342, 2017
212017
Phase 1/dose expansion trial of brentuximab vedotin and lenalidomide in relapsed or refractory diffuse large B-cell lymphoma
JP Ward, MM Berrien-Elliott, F Gomez, J Luo, M Becker-Hapak, ...
Blood, The Journal of the American Society of Hematology 139 (13), 1999-2010, 2022
192022
An international analysis evaluating frontline bendamustine with rituximab in extranodal marginal zone lymphoma
JP Alderuccio, L Arcaini, MP Watkins, AW Beaven, G Shouse, N Epperla, ...
Blood advances 6 (7), 2035-2044, 2022
182022
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20